BOSTON, MA--(Marketwired - August 19, 2014) - Amazing Charts, a 2014 Certified Electronic Health Record (EHR) system for outpatient practices, has named Duke Reilly as director of Industry Business Development. With the appointment, Amazing Charts signals a new focus on understanding how EHRs can help increase physician engagement through physician and patient education, data analytics and clinical research.
"We believe the EHR is much more than a screen for showing banner ads to physicians -- it is a platform for building deep relationships at the point of care for better patient outcomes, as well as for increasing the value pharmaceutical companies can deliver to primary care practices," said Reilly. "EHR systems also provide the data to measure everything from changes in physician behavior to trends in patient outcomes."
Reilly brings more than 15 years of pharmaceutical sales and marketing experience to Amazing Charts, having previously led branded and unbranded HCP and Medical Education initiatives at Wyeth and Pfizer.
"I am pleased to welcome Duke to the Amazing Charts team," said John Squire, president and COO of Amazing Charts. "Pri-Med, our parent company, already knows many of the brand teams in the therapeutic areas of vaccines and cardio metabolic, providing Duke with a strong head start on those initiatives."
About Amazing Charts
Amazing Charts provides Electronic Health Records (EHR/EMR) and services to healthcare practices. Based on number one user ratings for usability, fair pricing, and overall satisfaction, Amazing Charts has been adopted by more than 9,800 clinicians in nearly 6,700 private practices. Founded in 2001 by a family physician, today Amazing Charts.com, LLC operates as a subsidiary of Pri‐Med, an operating division of Diversified Communications (DC) and a trusted source for professional medical education to over 260,000 clinicians since 1995. For more information, visit: www.amazingcharts.com.
Amazing Charts is a trademark of Amazing Charts, LLC. All products or service names mentioned herein are trademarks of their respective owners.